US Broker Ratings

Envista Holdings Corporation (NVST) Stock Analysis: A 26.42% Potential Upside in the Dental Healthcare Sector

Envista Holdings Corporation (NYSE: NVST) is a key player in the healthcare sector, specializing in medical instruments and supplies, particularly in the dental industry. With a..

CG Oncology, Inc. (CGON) Stock Analysis: Navigating a 30.84% Potential Upside in the Biotechnology Sector

In the rapidly evolving landscape of biotechnology, CG Oncology, Inc. (NASDAQ: CGON) stands out as a noteworthy player, attracting significant attention from investors due to its..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Strong Buy Ratings and 22% Upside Potential

Investors in the biotech space are closely monitoring Travere Therapeutics, Inc. (NASDAQ: TVTX), a company that has carved a niche in addressing rare kidney and metabolic..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unpacking a 61.87% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) is standing at an intriguing juncture for biotechnology investors. With a significant market capitalization of $5.23 billion, this Switzerland-based company is..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Uncovering a Potential 201% Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is a name that has been catching the eye of investors in the healthcare sector, particularly those focusing on biotechnology. With..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a Remarkable 180% Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) presents an intriguing opportunity for investors searching for growth in the healthcare sector. With a market capitalization of $1.64 billion, Alignment..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring the 22.64% Upside in Biotech Innovation

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) has emerged as a compelling player in the biotechnology sector, boasting a market capitalization of $9.22 billion. Headquartered in Newark, California,..

Schrodinger, Inc. (SDGR) Stock Analysis: Unpacking Potential in Health Information Services Amid Market Challenges

Schrodinger, Inc. (NASDAQ: SDGR) presents a compelling case for investors navigating the healthcare sector, particularly within the niche of health information services. The company, with a..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 35% Upside Potential in the Biotech Sector

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is drawing significant attention in the biotechnology sector with its promising therapeutic pipeline and potential for robust growth. With its current..

Brookdale Senior Living Inc. (BKD) Stock Analysis: A Potential 74% Upside for Healthcare Investors

Brookdale Senior Living Inc. (NYSE: BKD) stands at a compelling crossroads for investors, particularly those with a focus on the healthcare sector. With a market cap..

Artivion, Inc. (AORT) Stock Analysis: A Strong Buy with 83% Upside Potential

Artivion, Inc. (AORT), a key player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors seeking growth and value...

Omnicell, Inc. (OMCL) Investor Outlook: Exploring a Significant 70.82% Potential Upside

In the dynamic landscape of healthcare technology, Omnicell, Inc. (NASDAQ: OMCL) emerges as a pivotal player. With a market capitalization of $1.54 billion, the company is..

SS Innovations International (SSII) Stock Analysis: A Potential 142% Upside in the Healthcare Sector

SS Innovations International, Inc. (SSII), a pioneering entity in the healthcare sector, specifically in medical devices, has captured investor attention with its innovative approach to surgical..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring the 3.21% Potential Upside

Pulse Biosciences, Inc (NASDAQ: PLSE), a healthcare innovator in the medical instruments and supplies industry, is garnering attention with its promising technologies and an attractive potential..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Navigating Market Volatility with Unique Product Offerings

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, specializes in the development, manufacturing, and marketing of both generic and proprietary injectable, inhalation,..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 111% Potential Upside in the Healthcare Sector

For investors keeping a keen eye on the medical device industry, Enovis Corporation (NYSE: ENOV) presents a compelling opportunity. With a substantial market cap of $1.05..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A 71.89% Potential Upside Sparks Investor Interest

Denali Therapeutics Inc. (NASDAQ: DNLI), a notable player in the biotechnology sector, is attracting significant attention from individual investors due to its promising portfolio targeting neurodegenerative..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Potential Upside of 94.67% for Biotech Innovator

Investors with an eye on the biotechnology sector might find Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) a compelling opportunity, given its focus on rare and ultra-rare genetic..

Neogen Corporation (NEOG) Stock Analysis: Evaluating Growth Potential in the Medical Devices Sector

Neogen Corporation (NASDAQ: NEOG), a pivotal player in the healthcare sector, specifically within the medical devices industry, offers a unique value proposition for investors focused on..

Haemonetics Corporation (HAE) Stock Analysis: A Strong Buy Signal with a 5.4% Upside Potential

Haemonetics Corporation (NYSE: HAE), a leader in the healthcare sector’s medical devices industry, is drawing significant attention from investors. With a solid market capitalization of $4.81..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds